qo a Op
赞了
📌 上周的 PDUFA:
$Heron Therapeutics (HRTX.US)$ : 1/23 获得批准 🎉
⇒ ZYNRELEF
⇒ 术后疼痛
⇒ snDa
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : 保密协议审查正在进行中 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA:24 年 1 月 24 日
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ Tesamorelin 的 F8 配方
⇒ 感染艾滋病毒的成年人腹部脂肪过多
⇒ sBla
⇒ PDUFA: 01/22/24
$赛诺菲安万特 (SNY.US)$ & $再生元制药公司 (REGN.US)$ : 1/25 获得批准 🎉
⇒ Dupixent
⇒ 嗜酸性食管炎(百科全书)
⇒ sB...
$Heron Therapeutics (HRTX.US)$ : 1/23 获得批准 🎉
⇒ ZYNRELEF
⇒ 术后疼痛
⇒ snDa
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : 保密协议审查正在进行中 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA:24 年 1 月 24 日
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ Tesamorelin 的 F8 配方
⇒ 感染艾滋病毒的成年人腹部脂肪过多
⇒ sBla
⇒ PDUFA: 01/22/24
$赛诺菲安万特 (SNY.US)$ & $再生元制药公司 (REGN.US)$ : 1/25 获得批准 🎉
⇒ Dupixent
⇒ 嗜酸性食管炎(百科全书)
⇒ sB...
已翻译
12
1
qo a Op
赞了
$Iovance Biotherapeutics (IOVA.US)$
Tumor infiltrating lymphocytes(TILs) cell therapy will see the transfomation from benchside to bedside after ~30 years of dedicated academic and industrial efforts!
1. Why TILs cell therapy has a high likelihood of getting a nod from FDA?
In this field, Iovance and the Netherlands Cancer Research are at the forefront of TILs development, both with a primary focus on advanced melanoma—a substantial market characterized by unm...
Tumor infiltrating lymphocytes(TILs) cell therapy will see the transfomation from benchside to bedside after ~30 years of dedicated academic and industrial efforts!
1. Why TILs cell therapy has a high likelihood of getting a nod from FDA?
In this field, Iovance and the Netherlands Cancer Research are at the forefront of TILs development, both with a primary focus on advanced melanoma—a substantial market characterized by unm...
4
1
$第一共和银行 (FRC.US)$ squeeze shorty out
4
1